BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell receptor signaling pathway
,
Leukemia
,
Hippocampus
,
Nosology
,
Lipitor
,
PTEN
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SOCS 3
Summary
General Info
Curated Studies
Most Correlated Studies
Ovarian cancer OVCAR-3 cells with POU5F1 siRNA, CCNF siRNA, PPP1R8 siRNA or RB1 siRNA
Renal gene expression profiles of epithelial and non-epithelial embryonic and adult tissue
Melanoma and hepatoma cell lines expressing SOCS1 and SOCS3 and INFA treated
Colonic mucosa in wildtype and conditional PPARg knockout CD4+ T cell mice with induced colitis
PBMCs after renal transplant and 3mo of cyclosporine, prednisone, and mycophenolate or azathioprine
Explore Curated Studies Results
Literature
Most Relevant Literature
AMPK-autophagy-mediated inhibition of microRNA-30a-5p alleviates morphine tolerance via SOCS3-depend…
Suppressor of cytokine signalling 3 (SOCS3) expressed in podocytes attenuates glomerulonephritis and…
Extracellular Vesicles Derived from Adipose-Derived Stem Cells Facilitate Frostbite Wound Healing By…
Research Advances on Suppressor of Cytokine Signaling 3 (SOCS3) in Animal Carbohydrate and Lipid Met…
IL-6 prevents Th2 cell polarization by promoting SOCS3-dependent suppression of IL-2 signaling.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)
A Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (S…
Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Part…
Clinical Study Of Affinity Versus SOC In The Management Of VLUs
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ